BR112014028362A2 - Ácidos (3r, 4r, 5s)-5-guanidino-4acetamido-3-(pentan- 3iloxi)cicloexeno-1-carboxílicos flúor substituídos, os seus ésteres e uso dos mesmos - Google Patents
Ácidos (3r, 4r, 5s)-5-guanidino-4acetamido-3-(pentan- 3iloxi)cicloexeno-1-carboxílicos flúor substituídos, os seus ésteres e uso dos mesmosInfo
- Publication number
- BR112014028362A2 BR112014028362A2 BR112014028362-1A BR112014028362A BR112014028362A2 BR 112014028362 A2 BR112014028362 A2 BR 112014028362A2 BR 112014028362 A BR112014028362 A BR 112014028362A BR 112014028362 A2 BR112014028362 A2 BR 112014028362A2
- Authority
- BR
- Brazil
- Prior art keywords
- pentan
- guanidino
- esters
- acids
- cycleexene
- Prior art date
Links
- 239000002253 acid Substances 0.000 title 1
- 150000007513 acids Chemical class 0.000 title 1
- 238000000034 method Methods 0.000 abstract 2
- 238000011321 prophylaxis Methods 0.000 abstract 2
- 238000011282 treatment Methods 0.000 abstract 2
- 125000006729 (C2-C5) alkenyl group Chemical group 0.000 abstract 1
- 125000006730 (C2-C5) alkynyl group Chemical group 0.000 abstract 1
- NMEZJSDUZQOPFE-UHFFFAOYSA-N Cyclohex-1-enecarboxylic acid Chemical class OC(=O)C1=CCCCC1 NMEZJSDUZQOPFE-UHFFFAOYSA-N 0.000 abstract 1
- JNCMHMUGTWEVOZ-UHFFFAOYSA-N F[CH]F Chemical compound F[CH]F JNCMHMUGTWEVOZ-UHFFFAOYSA-N 0.000 abstract 1
- 108010081348 HRT1 protein Hairy Proteins 0.000 abstract 1
- 102100021881 Hairy/enhancer-of-split related with YRPW motif protein 1 Human genes 0.000 abstract 1
- 102000005348 Neuraminidase Human genes 0.000 abstract 1
- 108010006232 Neuraminidase Proteins 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- VUWZPRWSIVNGKG-UHFFFAOYSA-N fluoromethane Chemical compound F[CH2] VUWZPRWSIVNGKG-UHFFFAOYSA-N 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 206010022000 influenza Diseases 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/16—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of rings other than six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2012119272/04A RU2489422C1 (ru) | 2012-05-12 | 2012-05-12 | Фторзамещенные (3r,4r,5s)-5-гуанидино-4-ациламино-3-(пентан-3-илокси)циклогексен-1-карбоновые кислоты, их эфиры и способ применения |
| RU2012119272 | 2012-05-12 | ||
| PCT/RU2013/000384 WO2013172741A2 (ru) | 2012-05-12 | 2013-05-07 | Фторзамещенные (3r,4r,5s)-5-гуанидино-4-ациламино-3-(пентан-3-илокси) циклогексен-1-карбоновые кислоты, их эфиры и способ применения |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112014028362A2 true BR112014028362A2 (pt) | 2018-04-17 |
| BR112014028362B1 BR112014028362B1 (pt) | 2022-02-01 |
Family
ID=49159508
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112014028362-1A BR112014028362B1 (pt) | 2012-05-12 | 2013-05-07 | Ácidos (3r, 4r, 5s)-5-guanidino-4-acetamido-3-(pentan-3-iloxi)cicloexeno-1-carboxílicos flúor substituídos, os seus ésteres, composição farmacêutica e uso da mesma |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US8895613B2 (pt) |
| EP (1) | EP2848606B1 (pt) |
| JP (1) | JP6034960B2 (pt) |
| KR (1) | KR101902567B1 (pt) |
| CN (1) | CN104284884B (pt) |
| AU (1) | AU2013263513B2 (pt) |
| BR (1) | BR112014028362B1 (pt) |
| CA (1) | CA2872733C (pt) |
| DK (1) | DK2848606T3 (pt) |
| EA (1) | EA024765B1 (pt) |
| HU (1) | HUE035856T2 (pt) |
| MX (1) | MX360369B (pt) |
| PL (1) | PL2848606T3 (pt) |
| RU (1) | RU2489422C1 (pt) |
| UA (1) | UA113201C2 (pt) |
| WO (1) | WO2013172741A2 (pt) |
| ZA (1) | ZA201408026B (pt) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103923060B (zh) * | 2014-03-27 | 2016-05-25 | 山东大学 | 奥司他韦衍生物及其制备方法和应用 |
| CN106905193B (zh) * | 2017-02-15 | 2018-11-27 | 中国药科大学 | 芳酰基胍基奥司他韦羧酸衍生物及其制备方法和应用 |
| US20190081317A1 (en) * | 2017-09-11 | 2019-03-14 | Andreas Keil | Web coating and calendering system and method |
| CN110272381A (zh) * | 2019-06-19 | 2019-09-24 | 五邑大学 | 含吡啶片段的奥司他韦类似物及其应用 |
| CN114057599A (zh) * | 2020-07-29 | 2022-02-18 | 广州市恒诺康医药科技有限公司 | 神经氨酸酶抑制剂类化合物、其药物组合物及其用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPM354694A0 (en) * | 1994-01-27 | 1994-02-17 | Biota Scientific Management Pty Ltd | Chemical compounds |
| SI9620042A (sl) * | 1995-02-27 | 1998-12-31 | Gilead Sciences, Inc. | Novi selektivni inhibitorji virusnih ali bakterijskih neuraminidaz |
| JP3233392B2 (ja) * | 1998-01-22 | 2001-11-26 | 三共株式会社 | ノイラミン酸誘導体を含有する抗インフルエンザ薬 |
| US6518048B2 (en) * | 2000-04-10 | 2003-02-11 | Hoffmann-La Roche Inc. | Stereo-specific synthesis of shimikic acid derivatives with improved efficiency |
| EP2276479B1 (en) * | 2008-04-15 | 2014-07-02 | SineVir Therapeutics LLC | Prodrugs of neuraminidase inhibitors |
| RU2469020C1 (ru) * | 2011-11-08 | 2012-12-10 | Александр Васильевич Иващенко | (3r,4r,5s)-5-амино-4-ациламино-3-(1-этил-пропокси)-циклогекс-1-ен-карбоновые кислоты, их эфиры и способ применения |
-
2012
- 2012-05-12 RU RU2012119272/04A patent/RU2489422C1/ru active
-
2013
- 2013-04-29 US US13/872,174 patent/US8895613B2/en active Active
- 2013-05-07 KR KR1020147034876A patent/KR101902567B1/ko active Active
- 2013-05-07 EA EA201401238A patent/EA024765B1/ru not_active IP Right Cessation
- 2013-05-07 WO PCT/RU2013/000384 patent/WO2013172741A2/ru not_active Ceased
- 2013-05-07 EP EP13791641.7A patent/EP2848606B1/en not_active Not-in-force
- 2013-05-07 PL PL13791641T patent/PL2848606T3/pl unknown
- 2013-05-07 BR BR112014028362-1A patent/BR112014028362B1/pt active IP Right Grant
- 2013-05-07 CN CN201380024800.0A patent/CN104284884B/zh active Active
- 2013-05-07 DK DK13791641.7T patent/DK2848606T3/en active
- 2013-05-07 AU AU2013263513A patent/AU2013263513B2/en not_active Ceased
- 2013-05-07 CA CA2872733A patent/CA2872733C/en not_active Expired - Fee Related
- 2013-05-07 JP JP2015512601A patent/JP6034960B2/ja active Active
- 2013-05-07 HU HUE13791641A patent/HUE035856T2/hu unknown
- 2013-05-07 MX MX2014013761A patent/MX360369B/es active IP Right Grant
- 2013-07-05 UA UAA201410979A patent/UA113201C2/uk unknown
-
2014
- 2014-11-03 ZA ZA2014/08026A patent/ZA201408026B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2013263513A1 (en) | 2014-11-06 |
| HUE035856T2 (hu) | 2018-05-28 |
| ZA201408026B (en) | 2015-11-25 |
| CA2872733A1 (en) | 2013-11-21 |
| DK2848606T3 (en) | 2017-10-02 |
| CN104284884B (zh) | 2016-07-13 |
| JP6034960B2 (ja) | 2016-11-30 |
| UA113201C2 (xx) | 2016-12-26 |
| WO2013172741A2 (ru) | 2013-11-21 |
| CA2872733C (en) | 2017-03-21 |
| AU2013263513B2 (en) | 2016-10-06 |
| BR112014028362B1 (pt) | 2022-02-01 |
| EA201401238A1 (ru) | 2015-02-27 |
| US20130303609A1 (en) | 2013-11-14 |
| EA024765B1 (ru) | 2016-10-31 |
| EP2848606A4 (en) | 2015-12-23 |
| CN104284884A (zh) | 2015-01-14 |
| EP2848606B1 (en) | 2017-08-30 |
| MX360369B (es) | 2018-10-29 |
| EP2848606A2 (en) | 2015-03-18 |
| JP2015521186A (ja) | 2015-07-27 |
| KR101902567B1 (ko) | 2018-09-28 |
| WO2013172741A3 (ru) | 2014-01-09 |
| MX2014013761A (es) | 2015-02-04 |
| KR20150017734A (ko) | 2015-02-17 |
| US8895613B2 (en) | 2014-11-25 |
| RU2489422C1 (ru) | 2013-08-10 |
| PL2848606T3 (pl) | 2018-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112012017382A2 (pt) | compostos inibidores de viroses flaviviridae, uso dos mesmos e composição farmacêutica | |
| BR112012001061B8 (pt) | glicosídeos 2,3-fluorados como inibidores de neuraminidase, seu método de preparação, composição farmacêutica que os compreende e embalagem comercial | |
| BR112012017402A2 (pt) | inibidores de vírus de flaviviridae | |
| BR112014030795A2 (pt) | composto, composição farmacêutica, uso de um composto e processo para preparação de um composto | |
| BR112014018990A8 (pt) | Derivados de ácido benzotiazol-6-il acético e seu uso para tratamento de uma infecção | |
| BR112013011580A2 (pt) | derivados de ácido bisfenil pentanoico substituído por amino como inibidores de nep | |
| BR112014010576B8 (pt) | compostos inibidores de neprilisina (nep), seus usos, processo de preparação dos compostos e composição farmacêutica compreendendo os compostos | |
| CL2013002737A1 (es) | Acido 4-((4-((((1r, 2s)-2-fenilciclopropil)amino)metil)piperidin-1-il)metil)benzoico con actividad inhibidora de desmetilasa 1 especifica de lisina (lsd1); composicion farmaceutica que lo comprende, utiles en el tratamiento del cancer. | |
| PH12013501704A1 (en) | Substituted aminobutyric derivatives as neprilysin inhibitors | |
| EA201391574A1 (ru) | Фармацевтически приемлемые сокристаллы n-[2-(7-метокси-1-нафтил)этил]ацетамида и способы их получения | |
| HK1200812A1 (en) | Rod -like hepatitis c virus inhibitors containing the fragement {2- [4- (bi phenyl - 4 - yl) - 1h - imidazo - 2 - yl] pyrrolidine - 1 - carbonlymethyl} amine | |
| EA201200728A1 (ru) | Новые сокристаллы агомелатина, способ их получения и фармацевтические композиции, которые их содержат | |
| BR112019003320A2 (pt) | compostos de heteroaril carboxamida como inibidores de ripk2 | |
| BR112014028362A2 (pt) | Ácidos (3r, 4r, 5s)-5-guanidino-4acetamido-3-(pentan- 3iloxi)cicloexeno-1-carboxílicos flúor substituídos, os seus ésteres e uso dos mesmos | |
| WO2010129057A8 (en) | Tetracycline compounds | |
| WO2014036502A8 (en) | Tetracycline compounds | |
| WO2011123536A8 (en) | Polycyclic tetracycline compounds | |
| BR112013017362A2 (pt) | composto de fórmula (i), processo para preparar um composto de fórmula (i), composição farmacêutica e compostos, métodos e usos inovadores | |
| WO2012161518A3 (ko) | ＲＯＲα의 활성자로서의 신규한 ｔｈｉｏｕｒｅａ 유도체 및 이를 함유하는 약학적 조성물 | |
| BR112013026361A2 (pt) | derivados de glicosídeo e usos dos mesmos | |
| MX2013007661A (es) | Derivados de fenil-isoxazol y procedimiento para la preparacion de los mismos. | |
| EA201591487A1 (ru) | Производные замещенной бисфенилбутановой кислоты в качестве ингибиторов nep с улучшенной in vivo эффективностью | |
| EA201391155A1 (ru) | Ингибитор катепсина с | |
| EA201391299A1 (ru) | Ингибиторы пептиддеформилазы | |
| BRPI0713523A8 (pt) | derivados de ácido fenilacético |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 07/05/2013, OBSERVADAS AS CONDICOES LEGAIS. |